Weilong Chang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- DNA Repair Mechanisms 2
- Circular RNAs in diseases 2
- Oncology 8
- Cancer-related Molecular Pathways 2
- Co-authors
- Kaixiong Tao (15 shared papers)Guobin Wang (7 shared papers)Weizhen Liu (4 shared papers)Yuping Yin (4 shared papers)Ruidong Li (4 shared papers)Zhen Yang (2 shared papers)Xiefu Zhang (3 shared papers)Gengchen Xie (3 shared papers)
- Journals
- PLoS ONE (2 papers)Cell Death and Disease (2 papers)Experimental Biology and Medicine (1 paper)Clinical Epigenetics (1 paper)Medicine (1 paper)
- Partner nations
- ChinaUnited StatesSerbia
In The Last Decade
Weilong Chang
29 papers receiving 665 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 149
- Gastroenterology 46
- Oncology 195
- Molecular Biology 282
- Cell Biology 60
Countries citing papers authored by Weilong Chang
This map shows the geographic impact of Weilong Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weilong Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weilong Chang more than expected).
Fields of papers citing papers by Weilong Chang
This network shows the impact of papers produced by Weilong Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weilong Chang. The network helps show where Weilong Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Weilong Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 66 | |
| 2 | 2015 | 54 | |
| 3 | 2016 | 49 | |
| 4 | 2019 | 47 | |
| 5 | Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancer. | 2017 | 46 |
| 6 | 2018 | 46 | |
| 7 | 2017 | 42 | |
| 8 | 2019 | 37 | |
| 9 | 2015 | 37 | |
| 10 | 2014 | 34 | |
| 11 | 2016 | 31 | |
| 12 | 2016 | 30 | |
| 13 | 2017 | 27 | |
| 14 | 2016 | 20 | |
| 15 | 2014 | 20 | |
| 16 | 2020 | 17 | |
| 17 | 2022 | 9 | |
| 18 | 2020 | 8 | |
| 19 | Primary splenic angiosarcoma with fever and anemia: a case report and literature review. | 2015 | 8 |
| 20 | 2024 | 7 |
About Weilong Chang
Weilong Chang is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Epidemiology, having authored 31 papers that have together received 671 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Gastrointestinal Tumor Research and Treatment (4 papers), Autophagy in Disease and Therapy (4 papers), Cancer-related molecular mechanisms research (3 papers), DNA Repair Mechanisms (2 papers), Circular RNAs in diseases (2 papers), Cancer-related Molecular Pathways (2 papers) and Cannabis and Cannabinoid Research (2 papers). The work is most often cited by research in Cancer Research (149 citations), Gastroenterology (46 citations), Oncology (195 citations), Molecular Biology (282 citations) and Cell Biology (60 citations). Weilong Chang has collaborated with scholars based in China, United States and Serbia. Frequent co-authors include Kaixiong Tao, Guobin Wang, Weizhen Liu, Yuping Yin, Ruidong Li, Zhen Yang, Xiefu Zhang, Gengchen Xie, Peng Zhang and Rui Deng. Their work appears in journals such as PLoS ONE, Cell Death and Disease, Experimental Biology and Medicine, Clinical Epigenetics and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.